The only conclusion I can come up with is that the initial TIS data and pics where fake. If a satisfactory answer is not forth-coming then I will consult the legal eagles. A company cannot go from TIS - 'it works but the sample size was too small' to FTT - 'nah it doesn't work', without a very good explanation.
Ann: Results of Phase 2 Clinical Trial, page-95
-
- There are more pages in this discussion • 62 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add DLM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.227M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| DLM (ASX) Chart |
Day chart unavailable